Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Change of serum growth factors in infants with isolated ventricular defect undergoing surgical repair
 
  • Details
Options

Change of serum growth factors in infants with isolated ventricular defect undergoing surgical repair

Journal
Annals of Thoracic Surgery
Date Issued
2002-01-01
Author(s)
YI-LIANG WU  
DOI
10.1016/S0003-4975(02)03500-2
URI
https://www.scopus.com/pages/publications/0036260101
https://scholars.csmu.edu.tw/handle/123456789/34041
Abstract
Background. Despite increasing clinical use and recent evidence that insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), and human growth hormone (hGH) target the heart, the clinical manifestations following the change in the serum growth factors in infants with isolated ventricular septal defect (VSD) undergoing surgical repair have not been clearly defined. Methods. Twenty normal infants (group I) and 44 consecutive infants with echocardiography established isolated VSD (aged from 3 months to 1 year; body weight from 6.0 ± 1.8 kg to 8.2 ± 1.6 kg) were investigated. Among 44 infants with VSD, 20 with shunt fraction, Qp/Qs ≤ 1.5 were free of symptoms of congestive heart failure (group II); 24 with shunt fraction, Qp/Qs ≥ 2.0 were in congestive heart failure (group IIIa); and 20 of these 24 infants had undergone VSD repair 6 months before their second study (group IIIb). Serum IGF-1, IGFBP-3, and hGH factors were determined by enzymelinked immunosorbent assay using a monoclonal antibody. Results. The serum levels of IGF-1, IGFBP-3, and hGH factors were 111.9 ± 2.3 ng/mL, 22.0 ± 2.3 ng/mL, and 3.6 ± 0.7 μIU/mL for group I; 63.8 ± 8.2 ng/mL, 17.1 ± 1.6 ng/mL, and 4.1 ± 1.2 μIU/mL for group II; 24.0 ± 2.6 ng/mL, 9.4 ± 0.7 ng/mL, and 14.7 ± 3.5 μIU/mL for group IIIa; 79.4 ± 12 ng/mL, 20.3 ± 1.3 ng/mL, and 4.3 ± 0.7 μIU/mL for group IIIb. In comparison to group I, the decrease in serum levels of IGF-1 and IGFBP-3 in groups II and IIIa were statistically significant (in group II 43% and 32%, p < 0.05; in group IIIa 79% and 37%, p < 0.01). Also the increase in serum level of hGH concentration in group IIIa was significant (increased threefold, p < 0.01). Interestingly, the change in serum levels of IGF-1, IGFBP-3 (decrease), and hGH (increase), returned to the normal range of serum levels after VSD repair in group IIIb. All congestive heart failure symptoms subsided in group IIIb during follow-up. Conclusions. Improvement in serum levels of IGF-1, IGFBP-3, and hGH were identified in infants with VSD after surgical repair.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback